Wellcome Sanger

the Wellcome Sanger Institute-led DtL project aims to sequence all roughly 70,000 eukaryotic species of Britain and Ireland, running one of the world's highest-throughput de novo assembly pipelines.

Country
United Kingdom
eu
Coverage
CNEUINUS
diagnostics-medtech
ecosystem-restoration
Regulatorsfdaemanmpausda-aphisefsamoa-china

Verifiable facts

FactValueSource
AffiliationThe Darwin Tree of Life (DToL) project is a partnership led by the Wellcome Sanger Institute, involving the Earlham Institute, EMBL-EBI, the Marine Biological Association, the Natural History Museum in London, the Royal Botanic Gardens Edinburgh, the Royal Botanic Gardens at Kew, CABI, the Institute of Zoology, and the universities of Cambridge, Edinburgh, Oxford, and Dublin.darwintreeoflife.org · sanger.ac.uk
Research focusGenerating high-quality reference genomes for all roughly 70,000 eukaryotic species in Britain and Ireland.pmc.ncbi.nlm.nih.gov · darwintreeoflife.org · sanger.ac.uk
FacilityWellcome Genome Campus, Hinxton, Cambridgeshire.seo-consultant.co · darwintreeoflife.org · sanger.ac.uk
GrantThe project is supported by funding from Wellcome, with an estimated initial cost of approximately £100 million for the first five years.sanger.ac.uk
PublicationsAs of the 2023-24 reporting period, the Tree of Life Programme published 482 Genome Notes, representing 61% year-on-year growth. In 2023-24, it contributed over 60% of all global submissions of high-quality, chromosomally complete genomes.pmc.ncbi.nlm.nih.gov · sanger.ac.uk
Principal staffMatthew Hurles (Director, Wellcome Sanger Institute); Head of the Tree of Life Programme.sanger.ac.uk
HeadcountThe Wellcome Sanger Institute employs multidisciplinary teams; it currently employs 116 postdocs (as of the 2024-25 financial year). The faculty size is comparatively small, numbering between 25 and 40 members.sanger.ac.uk

Independent sources: darwintreeoflife.org · pmc.ncbi.nlm.nih.gov · sanger.ac.uk · seo-consultant.co

Technologies
NameClusterRisk
Biodiversity genomicsecosystem-restorationLow
Genomic pathogen surveillance (service)diagnostics-medtechMedium

Compiled by BIOECON from primary sources.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.